Author
Listed:
- McLane J. Watson
(University of Pittsburgh
UPMC Hillman Cancer Center
University of Pittsburgh School of Medicine)
- Paolo D. A. Vignali
(University of Pittsburgh
UPMC Hillman Cancer Center
University of Pittsburgh School of Medicine)
- Steven J. Mullett
(University of Pittsburgh)
- Abigail E. Overacre-Delgoffe
(University of Pittsburgh
UPMC Children’s Hospital of Pittsburgh)
- Ronal M. Peralta
(University of Pittsburgh
UPMC Hillman Cancer Center
University of Pittsburgh School of Medicine)
- Stephanie Grebinoski
(University of Pittsburgh
University of Pittsburgh School of Medicine)
- Ashley V. Menk
(UPMC Hillman Cancer Center)
- Natalie L. Rittenhouse
(UPMC Children’s Hospital of Pittsburgh)
- Kristin DePeaux
(University of Pittsburgh
UPMC Hillman Cancer Center
University of Pittsburgh School of Medicine)
- Ryan D. Whetstone
(University of Pittsburgh
UPMC Hillman Cancer Center)
- Dario A. A. Vignali
(University of Pittsburgh
UPMC Hillman Cancer Center
UPMC Hillman Cancer Center)
- Timothy W. Hand
(UPMC Children’s Hospital of Pittsburgh
UPMC Hillman Cancer Center)
- Amanda C. Poholek
(UPMC Children’s Hospital of Pittsburgh)
- Brett M. Morrison
(Johns Hopkins University School of Medicine)
- Jeffrey D. Rothstein
(Johns Hopkins University School of Medicine)
- Stacy G. Wendell
(University of Pittsburgh
University of Pittsburgh)
- Greg M. Delgoffe
(University of Pittsburgh
UPMC Hillman Cancer Center
UPMC Hillman Cancer Center)
Abstract
Regulatory T (Treg) cells, although vital for immune homeostasis, also represent a major barrier to anti-cancer immunity, as the tumour microenvironment (TME) promotes the recruitment, differentiation and activity of these cells1,2. Tumour cells show deregulated metabolism, leading to a metabolite-depleted, hypoxic and acidic TME3, which places infiltrating effector T cells in competition with the tumour for metabolites and impairs their function4–6. At the same time, Treg cells maintain a strong suppression of effector T cells within the TME7,8. As previous studies suggested that Treg cells possess a distinct metabolic profile from effector T cells9–11, we hypothesized that the altered metabolic landscape of the TME and increased activity of intratumoral Treg cells are linked. Here we show that Treg cells display broad heterogeneity in their metabolism of glucose within normal and transformed tissues, and can engage an alternative metabolic pathway to maintain suppressive function and proliferation. Glucose uptake correlates with poorer suppressive function and long-term instability, and high-glucose conditions impair the function and stability of Treg cells in vitro. Treg cells instead upregulate pathways involved in the metabolism of the glycolytic by-product lactic acid. Treg cells withstand high-lactate conditions, and treatment with lactate prevents the destabilizing effects of high-glucose conditions, generating intermediates necessary for proliferation. Deletion of MCT1—a lactate transporter—in Treg cells reveals that lactate uptake is dispensable for the function of peripheral Treg cells but required intratumorally, resulting in slowed tumour growth and an increased response to immunotherapy. Thus, Treg cells are metabolically flexible: they can use ‘alternative’ metabolites in the TME to maintain their suppressive identity. Further, our results suggest that tumours avoid destruction by not only depriving effector T cells of nutrients, but also metabolically supporting regulatory populations.
Suggested Citation
McLane J. Watson & Paolo D. A. Vignali & Steven J. Mullett & Abigail E. Overacre-Delgoffe & Ronal M. Peralta & Stephanie Grebinoski & Ashley V. Menk & Natalie L. Rittenhouse & Kristin DePeaux & Ryan D, 2021.
"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid,"
Nature, Nature, vol. 591(7851), pages 645-651, March.
Handle:
RePEc:nat:nature:v:591:y:2021:i:7851:d:10.1038_s41586-020-03045-2
DOI: 10.1038/s41586-020-03045-2
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Qiang Feng & Zhida Liu & Xuexin Yu & Tongyi Huang & Jiahui Chen & Jian Wang & Jonathan Wilhelm & Suxin Li & Jiwon Song & Wei Li & Zhichen Sun & Baran D. Sumer & Bo Li & Yang-Xin Fu & Jinming Gao, 2022.
"Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity,"
Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Chi Zhou & Wenxin Li & Zhenxing Liang & Xianrui Wu & Sijing Cheng & Jianhong Peng & Kaixuan Zeng & Weihao Li & Ping Lan & Xin Yang & Li Xiong & Ziwei Zeng & Xiaobin Zheng & Liang Huang & Wenhua Fan & , 2024.
"Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death,"
Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Lanqi Gong & Jie Luo & Yu Zhang & Yuma Yang & Shanshan Li & Xiaona Fang & Baifeng Zhang & Jiao Huang & Larry Ka-Yue Chow & Dittman Chung & Jinlin Huang & Cuicui Huang & Qin Liu & Lu Bai & Yuen Chak Ti, 2023.
"Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction,"
Nature Communications, Nature, vol. 14(1), pages 1-24, December.
- Kang Wang & Ioannis Zerdes & Henrik J. Johansson & Dhifaf Sarhan & Yizhe Sun & Dimitris C. Kanellis & Emmanouil G. Sifakis & Artur Mezheyeuski & Xingrong Liu & Niklas Loman & Ingrid Hedenfalk & Jonas , 2024.
"Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer,"
Nature Communications, Nature, vol. 15(1), pages 1-24, December.
- Luca Simula & Mattia Fumagalli & Lene Vimeux & Irena Rajnpreht & Philippe Icard & Gary Birsen & Dongjie An & Frédéric Pendino & Adrien Rouault & Nadège Bercovici & Diane Damotte & Audrey Lupo-Mansuet , 2024.
"Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors,"
Nature Communications, Nature, vol. 15(1), pages 1-23, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:591:y:2021:i:7851:d:10.1038_s41586-020-03045-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.